Annual D&A
$941.00 K
+$43.00 K+4.79%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual depreciation & amortization is $941.00 thousand, with the most recent change of +$43.00 thousand (+4.79%) on December 31, 2023.
- During the last 3 years, MTNB annual D&A has risen by +$166.40 thousand (+21.48%).
- MTNB annual D&A is now at all-time high.
Performance
MTNB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$244.00 K
+$3000.00+1.24%
September 30, 2024
Summary
- As of February 7, 2025, MTNB quarterly depreciation & amortization is $244.00 thousand, with the most recent change of +$3000.00 (+1.24%) on September 30, 2024.
- Over the past year, MTNB quarterly D&A has increased by +$6000.00 (+2.52%).
- MTNB quarterly D&A is now at all-time high.
Performance
MTNB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$965.00 K
+$6000.00+0.63%
September 30, 2024
Summary
- As of February 7, 2025, MTNB TTM depreciation & amortization is $965.00 thousand, with the most recent change of +$6000.00 (+0.63%) on September 30, 2024.
- Over the past year, MTNB TTM D&A has increased by +$38.00 thousand (+4.10%).
- MTNB TTM D&A is now at all-time high.
Performance
MTNB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
MTNB Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.8% | +2.5% | +4.1% |
| 3 y3 years | +21.5% | +2.5% | +4.1% |
| 5 y5 years | +331.1% | +2.5% | +4.1% |
MTNB Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.5% | at high | +19.3% | at high | +23.6% |
| 5 y | 5-year | at high | +21.5% | at high | +33.5% | at high | +27.0% |
| alltime | all time | at high | >+9999.0% | at high | +2564.7% | at high | -100.0% |
Matinas BioPharma Holdings Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $244.00 K(+1.2%) | $965.00 K(+0.6%) |
| Jun 2024 | - | $241.00 K(+0.4%) | $959.00 K(+0.7%) |
| Mar 2024 | - | $240.00 K(0.0%) | $952.00 K(+1.2%) |
| Dec 2023 | $941.00 K(+4.8%) | $240.00 K(+0.8%) | $941.00 K(+1.5%) |
| Sep 2023 | - | $238.00 K(+1.7%) | $927.00 K(+0.9%) |
| Jun 2023 | - | $234.00 K(+2.2%) | $919.00 K(+0.3%) |
| Mar 2023 | - | $229.00 K(+1.3%) | $916.00 K(+2.0%) |
| Dec 2022 | $898.00 K(+15.0%) | $226.00 K(-1.7%) | $898.00 K(+2.4%) |
| Sep 2022 | - | $230.00 K(-0.4%) | $876.60 K(+4.0%) |
| Jun 2022 | - | $231.00 K(+9.5%) | $842.60 K(+6.1%) |
| Mar 2022 | - | $211.00 K(+3.1%) | $794.40 K(+1.7%) |
| Dec 2021 | $781.00 K(+0.8%) | $204.60 K(+4.4%) | $781.00 K(+1.8%) |
| Sep 2021 | - | $196.00 K(+7.2%) | $767.40 K(+1.0%) |
| Jun 2021 | - | $182.80 K(-7.5%) | $760.00 K(-1.8%) |
| Mar 2021 | - | $197.60 K(+3.5%) | $773.80 K(-0.1%) |
| Dec 2020 | $774.60 K(-0.8%) | $191.00 K(+1.3%) | $774.70 K(-0.9%) |
| Sep 2020 | - | $188.60 K(-4.1%) | $781.60 K(-0.3%) |
| Jun 2020 | - | $196.60 K(-1.0%) | $783.90 K(-0.1%) |
| Mar 2020 | - | $198.50 K(+0.3%) | $784.80 K(+0.5%) |
| Dec 2019 | $780.80 K(+257.7%) | $197.90 K(+3.7%) | $780.80 K(+21.1%) |
| Sep 2019 | - | $190.90 K(-3.3%) | $644.60 K(+26.3%) |
| Jun 2019 | - | $197.50 K(+1.5%) | $510.20 K(+39.6%) |
| Mar 2019 | - | $194.50 K(+215.2%) | $365.60 K(+67.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $218.30 K(+117.0%) | $61.70 K(+9.2%) | $218.20 K(+8.6%) |
| Sep 2018 | - | $56.50 K(+6.8%) | $200.90 K(+14.3%) |
| Jun 2018 | - | $52.90 K(+12.3%) | $175.80 K(+29.6%) |
| Mar 2018 | - | $47.10 K(+6.1%) | $135.70 K(+34.9%) |
| Dec 2017 | $100.60 K(+91.3%) | $44.40 K(+41.4%) | $100.60 K(+46.0%) |
| Sep 2017 | - | $31.40 K(+145.3%) | $68.90 K(+34.6%) |
| Jun 2017 | - | $12.80 K(+6.7%) | $51.20 K(-1.2%) |
| Mar 2017 | - | $12.00 K(-5.5%) | $51.80 K(-1.7%) |
| Dec 2016 | $52.60 K(+20.9%) | $12.70 K(-7.3%) | $52.70 K(+3.7%) |
| Sep 2016 | - | $13.70 K(+2.2%) | $50.80 K(+3.3%) |
| Jun 2016 | - | $13.40 K(+3.9%) | $49.20 K(+8.1%) |
| Mar 2016 | - | $12.90 K(+19.4%) | $45.50 K(+4.6%) |
| Dec 2015 | $43.50 K(+4.6%) | $10.80 K(-10.7%) | $43.50 K(+90.8%) |
| Sep 2015 | - | $12.10 K(+24.7%) | $22.80 K(-46.1%) |
| Jun 2015 | - | $9700.00(-11.0%) | $42.30 K(-1.9%) |
| Mar 2015 | - | $10.90 K(-210.1%) | $43.10 K(+3.4%) |
| Dec 2014 | $41.60 K(+3681.8%) | -$9900.00(-131.3%) | $41.70 K(-20.0%) |
| Sep 2014 | - | $31.60 K(+201.0%) | $52.10 K(+196.0%) |
| Jun 2014 | - | $10.50 K(+10.5%) | $17.60 K(+64.5%) |
| Mar 2014 | - | $9500.00(+1800.0%) | $10.70 K(+791.7%) |
| Dec 2013 | $1100.00 | $500.00(-117.2%) | $1200.00(+71.4%) |
| Sep 2013 | - | -$2900.00(-180.6%) | $700.00(-80.6%) |
| Jun 2013 | - | $3600.00(>+9900.0%) | $3600.00(>+9900.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
FAQ
- What is Matinas BioPharma Holdings annual depreciation & amortization?
- What is the all time high annual D&A for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual D&A year-on-year change?
- What is Matinas BioPharma Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly D&A year-on-year change?
- What is Matinas BioPharma Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings TTM D&A year-on-year change?
What is Matinas BioPharma Holdings annual depreciation & amortization?
The current annual D&A of MTNB is $941.00 K
What is the all time high annual D&A for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual depreciation & amortization is $941.00 K
What is Matinas BioPharma Holdings annual D&A year-on-year change?
Over the past year, MTNB annual depreciation & amortization has changed by +$43.00 K (+4.79%)
What is Matinas BioPharma Holdings quarterly depreciation & amortization?
The current quarterly D&A of MTNB is $244.00 K
What is the all time high quarterly D&A for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly depreciation & amortization is $244.00 K
What is Matinas BioPharma Holdings quarterly D&A year-on-year change?
Over the past year, MTNB quarterly depreciation & amortization has changed by +$6000.00 (+2.52%)
What is Matinas BioPharma Holdings TTM depreciation & amortization?
The current TTM D&A of MTNB is $965.00 K
What is the all time high TTM D&A for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM depreciation & amortization is $965.00 K
What is Matinas BioPharma Holdings TTM D&A year-on-year change?
Over the past year, MTNB TTM depreciation & amortization has changed by +$38.00 K (+4.10%)